Reneuron Share Discussion Threads

[easwarareddy] 11/1/2016 07:45

Should give share price a boost as news filters

[rocket fuel] 07/1/2016 14:53

Normal sevice resumes.
Target trading range 1p - 2p

[ftangftang] 04/1/2016 16:36

ReNeuron Group PLC (LON:RENE) had its stock rating reiterated as ‘Buy’ in a report released by analysts at N+1 Singer.

N+1 Singer today set a target price of 10 on the company’s stock. According to the analyst this now indicates there is a potential increase of 222.58% from ReNeuron Group PLC’s current price of 3.1.

LON:RENE

Over the last twelve months ReNeuron Group PLC’s stock price has increased by 0% from 0.00 to 3.1 .

There are currently 2,058,105,000 shares in issue with a current share value of 3.1 giving ReNeuron Group PLC a market capitalisation of 63.80M GBp .

ReNeuron Group PLC (LON:RENE) has a 50 day moving average of 2.92 and a 200 day moving average of 4.41. The 52 week high for the share price is 6.5 while the 52 week low for the stock is 2.26.
ReNeuron Group Plc (ReNeuron), based in the United Kingdom, is engaged in clinical-stage stem cell company. It is engaged in the research, development and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications. It develops cell-based therapies for disease conditions where the cells can be readily administered off-the-shelf to any eligible patient without the need for additional drug treatments. Its lead therapeutic candidate is its ReN001 stem cell therapy for the treatment of patients left disabled by the effects of a stroke. Its ReNcell products are used in academic and commercial sectors. Its ReN009 stem cell candidate is for the treatment of critical limb ischaemia, a side effect of diabetes. This treatment is in early-stage clinical development. Its ReN003 stem cell candidate is for the treatment of retina pigmentosa, a blindness-causing disease of the retina. This treatment is in late pre-clinical development




cheers
ft ft

[ftangftang] 04/1/2016 16:36

10p .... mmm

cheers
ft ft

[tradeyodha] 04/1/2016 12:09

Looking nice. First target at 3.5 p as planned

[ballychan] 04/1/2016 11:48

Hi Costax, sorry can you elaborate? Who is bhrd?

[easwarareddy] 01/1/2016 03:18

When is this share going to go back to the 5p levels!

[dickbush] 21/12/2015 10:00

Thanks, algernon2. Good to see them marketing the company's prospects.

[elgordo] 19/12/2015 11:41

Excellent overview and review of progress - recommended viewing. Thanks, algernon2.

[algernon2] 19/12/2015 01:01

ReNeuron CFO Michael Hunt Presents at the Biotech Capital Conference

Some interesting updates on progression here:

[bigspuds] 18/12/2015 18:35

And so do I lol

[rocket fuel] 18/12/2015 12:21

they are currently burning £2m cash per month since october and will be burning £2.5m+ per month from next april.
rene know how to ride a gravy train.

[dickbush] 18/12/2015 12:04

I can't do that. They're crossed.

[semper vigilans] 18/12/2015 10:55

Toes ? I'd count you fingers.

[dickbush] 18/12/2015 10:53

FWIW I now have a couple of toes in RENE at an average of just less than 3p including expenses.

[dickbush] 17/12/2015 11:50

RENE has obviously gained an impressive reputation in the industry to be able to attract these people. Let's hope their contributions outweigh their costs.

[rocket fuel] 17/12/2015 11:00

another nine mouths to feed!

[ftangftang] 17/12/2015 07:37

Commenting on the formation of the Scientific Advisory Board, Olav Hellebø, ReNeuron's CEO, said:

"We are honoured to have attracted such a prestigious group of leading, international academics and industry executives to our Scientific Advisory Board. The Company has always sought the advice and input of scientific and other experts when required as its research and development programmes have progressed. The formal establishment of our SAB will enable the business to harness the collective knowledge of the SAB members across all aspects of drug development which will be invaluable as we drive our therapeutic programmes through the clinic and progress our exciting early stage work in exosomes."

cheers
ft ft

[norbus] 14/12/2015 16:03

So long as they are straight arrows and not bent

[verger] 10/12/2015 13:32

Happy the man who has a quiver full of arrows!

[norbus] 10/12/2015 09:20

a boat sinks when it carries too much cargo